Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Acadia_Pharmaceuticals> ?p ?o. }
Showing items 1 to 67 of
67
with 100 items per page.
- Acadia_Pharmaceuticals abstract "ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders. ACADIA has a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson’s disease psychosis. Pimavanserin is also in Phase II development for Alzheimer’s disease psychosis and has successfully completed a Phase II trial as a co-therapy for schizophrenia. ACADIA also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. and two advanced preclinical programs directed at Parkinson’s disease and other neurological disorders. All product candidates are small molecules that emanate from internal discoveries.".
- Acadia_Pharmaceuticals assets "189.12".
- Acadia_Pharmaceuticals foundingYear "1993".
- Acadia_Pharmaceuticals industry Biopharmaceutical.
- Acadia_Pharmaceuticals industry Health_care.
- Acadia_Pharmaceuticals keyPerson Chief_executive_officer.
- Acadia_Pharmaceuticals location California.
- Acadia_Pharmaceuticals location San_Diego.
- Acadia_Pharmaceuticals location United_States.
- Acadia_Pharmaceuticals numberOfEmployees "52".
- Acadia_Pharmaceuticals product Pimavanserin.
- Acadia_Pharmaceuticals revenue "1.15".
- Acadia_Pharmaceuticals thumbnail ACADIA_logo.gif?width=300.
- Acadia_Pharmaceuticals type Public_company.
- Acadia_Pharmaceuticals wikiPageExternalLink www.acadia-pharm.com.
- Acadia_Pharmaceuticals wikiPageID "31349406".
- Acadia_Pharmaceuticals wikiPageRevisionID "606698438".
- Acadia_Pharmaceuticals assets "$189.12M( )".
- Acadia_Pharmaceuticals foundation "1993".
- Acadia_Pharmaceuticals hasPhotoCollection Acadia_Pharmaceuticals.
- Acadia_Pharmaceuticals homepage www.acadia-pharm.com.
- Acadia_Pharmaceuticals industry Biopharmaceutical.
- Acadia_Pharmaceuticals industry Health_care.
- Acadia_Pharmaceuticals keyPeople "(CEO)".
- Acadia_Pharmaceuticals keyPeople "Dr. Uli Hacksell".
- Acadia_Pharmaceuticals location California.
- Acadia_Pharmaceuticals location San_Diego.
- Acadia_Pharmaceuticals location United_States.
- Acadia_Pharmaceuticals logo File:ACADIA_logo.gif.
- Acadia_Pharmaceuticals name "ACADIA Pharmaceuticals".
- Acadia_Pharmaceuticals netIncome "$( )".
- Acadia_Pharmaceuticals numEmployees "52".
- Acadia_Pharmaceuticals operatingIncome "$( )".
- Acadia_Pharmaceuticals products Pimavanserin.
- Acadia_Pharmaceuticals revenue "$1.15M( )".
- Acadia_Pharmaceuticals type Public_company.
- Acadia_Pharmaceuticals subject Category:Pharmaceutical_companies_of_the_United_States.
- Acadia_Pharmaceuticals type Abstraction100002137.
- Acadia_Pharmaceuticals type CompaniesInTheNASDAQBiotechnologyIndex.
- Acadia_Pharmaceuticals type Company108058098.
- Acadia_Pharmaceuticals type DrugCompany108002578.
- Acadia_Pharmaceuticals type Group100031264.
- Acadia_Pharmaceuticals type Institution108053576.
- Acadia_Pharmaceuticals type Organization108008335.
- Acadia_Pharmaceuticals type PharmaceuticalCompaniesOfTheUnitedStates.
- Acadia_Pharmaceuticals type SocialGroup107950920.
- Acadia_Pharmaceuticals type YagoLegalActor.
- Acadia_Pharmaceuticals type YagoLegalActorGeo.
- Acadia_Pharmaceuticals type YagoPermanentlyLocatedEntity.
- Acadia_Pharmaceuticals type Agent.
- Acadia_Pharmaceuticals type Company.
- Acadia_Pharmaceuticals type Organisation.
- Acadia_Pharmaceuticals type Organization.
- Acadia_Pharmaceuticals type Agent.
- Acadia_Pharmaceuticals type SocialPerson.
- Acadia_Pharmaceuticals type Thing.
- Acadia_Pharmaceuticals comment "ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders. ACADIA has a pipeline of product candidates led by pimavanserin, which is in Phase III development as a potential first-in-class treatment for Parkinson’s disease psychosis.".
- Acadia_Pharmaceuticals label "Acadia Pharmaceuticals".
- Acadia_Pharmaceuticals sameAs m.03p1cpg.
- Acadia_Pharmaceuticals sameAs Q4671580.
- Acadia_Pharmaceuticals sameAs Q4671580.
- Acadia_Pharmaceuticals sameAs Acadia_Pharmaceuticals.
- Acadia_Pharmaceuticals wasDerivedFrom Acadia_Pharmaceuticals?oldid=606698438.
- Acadia_Pharmaceuticals depiction ACADIA_logo.gif.
- Acadia_Pharmaceuticals homepage www.acadia-pharm.com.
- Acadia_Pharmaceuticals isPrimaryTopicOf Acadia_Pharmaceuticals.
- Acadia_Pharmaceuticals name "ACADIA Pharmaceuticals".